LSTA
Lisata Therapeutics, Inc.
There isn't enough reported data to score LSTA yet.
LSTA Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Unavailable |
LSTA's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
LSTA PE Valuation
LSTA has no meaningful PE right now: it lost money over the past year.
LSTA Forward outlook
There aren't enough analyst estimates for LSTA to show an outlook.
LSTA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.64 | +$0.59 |
| Q1 2026 | -$1.86 | +$0.44 |
| Q4 2025 | -$1.91 | +$0.49 |
| Q3 2025 | -$2.13 | +$0.38 |
| Q2 2025 | -$2.23 | +$0.34 |
| Q1 2025 | -$2.30 | +$0.16 |
| Q4 2024 | -$2.40 | +$0.18 |
| Q3 2024 | -$2.51 | +$1.82 |
LSTA is still losing money, but far less than before: $1.64 per share over the past year, against $28.20 at its worst in late 2019.
LSTA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $100K | -90% |
LSTA's revenue has slid since its 2024 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -3079% | -2584 points |
| Q2 2025 | -6954% | N/A |
| Q4 2024 | -495% | N/A |
LSTA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.6M | +$1.3M |
| Q1 2026 | -$3.1M | +$2.3M |
| Q4 2025 | -$3.2M | +$1.3M |
| Q3 2025 | -$3.3M | -$824K |
| Q2 2025 | -$4M | +$1.3M |
| Q1 2025 | -$5.4M | +$1.6M |
| Q4 2024 | -$4.5M | -$459K |
| Q3 2024 | -$2.5M | +$1.1M |
LSTA has burned cash in almost every quarter: −$12M over the past year, against −$16M the year before.
LSTA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +100K shares |
| 1 year | +5.8% | +501K shares |
| 3 years | +14% | +1.1M shares |
| 5 years | +224% | +6.3M shares |
| Available history | +1212% | +8.4M shares |
LSTA has 9M diluted shares, up 5.8% from a year ago.
LSTA Net Leverage
LSTA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LSTA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.5 | Neutral |
| Stochastic | 9.3 | Oversold |
LSTA's weekly RSI is 38 (neutral) and its Stochastic is 9 (oversold).
LSTA PE vs Healthcare Sector
LSTA has no meaningful PE right now: it lost money over the past year.
LSTA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.18 | 8.5% above |
| 20 week MA | $1.63 | 21% below |
| 50 week MA | $2.77 | 54% below |
| 100 week MA | $2.65 | 52% below |
| 200 week MA | $2.84 | 55% below |
LSTA has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 55% below its 200-week average.
LSTA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.8 | $22.8 | -32% |
| 2021 | $22.8 | $13.7 | -40% |
| 2022 | $13.7 | $2.50 | -82% |
| 2023 | $2.50 | $2.73 | +9.2% |
| 2024 | $2.73 | $3.02 | +11% |
| 2025 | $3.02 | $1.97 | -35% |
| 2026 YTD | $1.97 | $1.28 | -35% |
LSTA has finished lower in four of the last six years. It's down 35% so far in 2026.